India's next major manufacturing opportunity may emerge not from information technology or semiconductors, but from medical devices. According to a recent report from Rubix Industry Insights, India's medical-device market is projected to increase from $15.2 billion in 2025 to $50.1 billion by 2030, representing a compound annual growth rate of 26.9%. That projected expansion would place medical devices among India's faster-growing industrial and healthcare segments (https://ibn.fm/19Onj).
The timing is particularly relevant for SS Innovations International (NASDAQ: SSII), which is developing and commercializing surgical robotic technology from India while expanding the international footprint of its flagship SSi Mantra system. As India pushes to reduce import dependence in medical devices, SSII is well-positioned to capitalize on both domestic and export opportunities.
SS Innovations has already installed 224 SSi Mantra systems across 12 countries as of June 30, providing an established platform as India expands its MedTech manufacturing ambitions. The company is actively seeking both US FDA clearance and European Union CE mark certification to expand its global reach.
The projected growth in India's medical-device market is driven by factors such as increasing healthcare spending, a growing aging population, and government initiatives to boost local manufacturing. For SSII, this could create opportunities extending beyond domestic sales into manufacturing, exports, and international technology adoption.
As India's medical-device market surges, SS Innovations is poised to benefit from the country's push to become a global hub for medical technology. With its established presence and expanding product portfolio, the company is well-positioned to leverage this growth trend.
